|
|
|
|
World Courier
|
|
Customising the Cold Chain
|
|
Of all the statistics emerging around the global pharmaceutical industry
this year, two big numbers capture the attention of both manufacturers
and their logistics partners: $248 billion, the amount the “BRIC”
nations (Brazil, Russia, India and China) are poised to account for in
pharmaceutical sales for by 2016; and $8 billion, the amount global
pharma will spend on cold chain logistics in 2014. Why are these two
numbers so noteworthy? They demonstrate that as R&D goes, so goes
logistics. As products evolve to meet demands for more targeted
therapies, demand for more targeted logistics solutions grows as well.
And that means a need for customization for everything from clinical
trial samples to finished product.
|
|
|
|
|
|
|
|
 |
News and Press Releases |
 |
ERT and Science 37 Partner to Deliver High-Quality Data during Virtual Trials
ERT, the global leader in clinical endpoint data collection and Science
37, the leader in decentralized clinical trials, today announced a
partnership enabling ERT’s Cardiac Safety, Respiratory, and Imaging
solutions to be incorporated into the Science 37 virtual, or
decentralized clinical trial offering. The combined solution
significantly improves data quality while dramatically reducing patient
burden.
More info >> |
|
 |
White Papers |
 |
|
Maximize the ROI of Your Post-Approval Research
Bioclinica
Expenditures in post-approval (Phase IV) research are going up across the pharmaceutical, biotech and medical device industries. Given the resources you’ve committed to post-approval research, you may be wondering if you’re getting the greatest possible return on your investment.
Discover how to harness the power of post-approval research to increase data collection, reduce resource burn, save money, and maximize your ROI!
More info >> |
|
 |
Industry Events |
 |
Clinical Operations in Oncology Trials West Coast
17-18 November 2020, Hilton San Francisco Airport Bayfront
Clinical Operations in Oncology Trials West Coast will be returning this April for another 2 day event full of thought-provoking presentations, discussions and roundtables. This years' conference highlights include the high-level, interactive immuno-oncology discussion panel where specialists from Shasta Bio Ventures, Abbvie and BeiGene shared their top tips on how to run successful and impactful immuno-oncology studies.
More info >> |
|
|
|
.jpg)
